Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor.
Hamacher R, Pabst KM, Cheung PF, Heilig CE, Hüllein J, Liffers ST, Borchert S, Costa PF, Schaarschmidt BM, Kessler L, Miera MA, Droste M, Akbulut M, Falkenhorst J, Zarrad F, Kostbade K, Mavroeidi IA, Glimm H, Umutlu L, Schuler M, Hübschmann D, Bauer S, Fröhling S, Herrmann K, Siveke JT, Schildhaus HU, Fendler WP. Hamacher R, et al. J Nucl Med. 2024 Feb 1;65(2):252-257. doi: 10.2967/jnumed.123.266411. J Nucl Med. 2024. PMID: 38176718
Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients.
Ferdinandus J, Costa PF, Kessler L, Weber M, Hirmas N, Kostbade K, Bauer S, Schuler M, Ahrens M, Schildhaus HU, Rischpler C, Grafe H, Siveke JT, Herrmann K, Fendler WP, Hamacher R. Ferdinandus J, et al. Among authors: hamacher r. J Nucl Med. 2022 May;63(5):727-734. doi: 10.2967/jnumed.121.262468. Epub 2021 Aug 12. J Nucl Med. 2022. PMID: 34385340 Free PMC article.
Lesion Quantification Accuracy of Digital 90Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide Therapy.
Kersting D, Jentzen W, Jeromin D, Mavroeidi IA, Conti M, Büther F, Herrmann K, Rischpler C, Hamacher R, Fendler WP, Seifert R, Costa PF. Kersting D, et al. Among authors: hamacher r. J Nucl Med. 2023 Feb;64(2):329-336. doi: 10.2967/jnumed.122.264338. Epub 2022 Aug 18. J Nucl Med. 2023. PMID: 35981898 Free PMC article.
Equivalent tumor detection for early and late FAPI-46 PET acquisition.
Ferdinandus J, Kessler L, Hirmas N, Trajkovic-Arsic M, Hamacher R, Umutlu L, Nader M, Zarrad F, Weber M, Fendler WP. Ferdinandus J, et al. Among authors: hamacher r. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3221-3227. doi: 10.1007/s00259-021-05266-7. Epub 2021 Feb 23. Eur J Nucl Med Mol Imaging. 2021. PMID: 33620560 Free PMC article.
Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis.
Kessler L, Ferdinandus J, Hirmas N, Zarrad F, Nader M, Kersting D, Weber M, Kazek S, Sraieb M, Hamacher R, Lueckerath K, Umutlu L, Fendler WP, Rischpler C. Kessler L, et al. Among authors: hamacher r. J Nucl Med. 2022 Jun;63(6):890-896. doi: 10.2967/jnumed.121.262808. Epub 2021 Oct 7. J Nucl Med. 2022. PMID: 34620730 Free PMC article.
Safety and Efficacy of 90Y-FAPI-46 Radioligand Therapy in Patients with Advanced Sarcoma and Other Cancer Entities.
Fendler WP, Pabst KM, Kessler L, Fragoso Costa P, Ferdinandus J, Weber M, Lippert M, Lueckerath K, Umutlu L, Kostbade K, Mavroeidi IA, Schuler M, Ahrens M, Rischpler C, Bauer S, Herrmann K, Siveke JT, Hamacher R. Fendler WP, et al. Among authors: hamacher r. Clin Cancer Res. 2022 Oct 3;28(19):4346-4353. doi: 10.1158/1078-0432.CCR-22-1432. Clin Cancer Res. 2022. PMID: 35833949 Free PMC article.
New therapeutic agents in gastrointestinal stromal tumours.
Falkenhorst J, Hamacher R, Bauer S. Falkenhorst J, et al. Among authors: hamacher r. Curr Opin Oncol. 2019 Jul;31(4):322-328. doi: 10.1097/CCO.0000000000000549. Curr Opin Oncol. 2019. PMID: 31033566 Review.
48 results